Stay updated on Satralizumab in Generalized Myasthenia Gravis Clinical Trial
Sign up to get notified when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.

Latest updates to the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe Taiwan study site entry is updated from 'Taoyuan, Taiwan, 333' to 'Taoyuan City, Taiwan, 333' to reflect the correct city designation.SummaryDifference0.0%

- Check15 days agoChange DetectedThe page footer has been updated to reflect a new ClinicalTrials.gov release revision (v3.5.3 instead of v3.5.2).SummaryDifference0.0%

- Check22 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check51 days agoChange DetectedThe Italy location entry was updated from Napoli, Campania, 80131 to Naples, Campania, 80131. The page revision label changed from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing Revision: v3.4.2. This appears to be a small administrative update with no changes to study details.SummaryDifference0.0%

- Check72 days agoChange DetectedResults have been posted for the study and the status updated to Terminated; the page now reflects the published outcomes.SummaryDifference0.0%

Stay in the know with updates to Satralizumab in Generalized Myasthenia Gravis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.